Immediate Impact
70 standout
Citing Papers
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis
2023 Standout
Works of Jacqueline Joza being referenced
Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome
2014
In-Hospital Management of Atrial Fibrillation: The CHADS2 Score Predicts Increased Cost
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jacqueline Joza | 727 | 64 | 50 | 71 | 49 | 764 | |
| Yitschak Biton | 669 | 33 | 16 | 89 | 44 | 728 | |
| Kevin Jackson | 872 | 36 | 17 | 79 | 66 | 939 | |
| José Luis Martínez‐Sande | 876 | 41 | 24 | 141 | 74 | 947 | |
| Olivier Piot | 842 | 49 | 29 | 80 | 55 | 914 | |
| Jeffrey Cerkvenik | 918 | 43 | 24 | 79 | 23 | 979 | |
| Carsten Lennerz | 646 | 17 | 50 | 76 | 73 | 731 | |
| Amin Al‐Ahmad | 745 | 42 | 34 | 82 | 48 | 813 | |
| Stefan G. Spitzer | 783 | 31 | 67 | 96 | 61 | 889 | |
| Nathalie Béhar | 639 | 37 | 42 | 65 | 53 | 680 | |
| Jo Jo Hai | 582 | 33 | 111 | 77 | 53 | 724 |
All Works
Login with ORCID to disown or claim papers
Loading papers...